DE60310708D1 - In vivo stabilsierung von plasmiden - Google Patents

In vivo stabilsierung von plasmiden

Info

Publication number
DE60310708D1
DE60310708D1 DE60310708T DE60310708T DE60310708D1 DE 60310708 D1 DE60310708 D1 DE 60310708D1 DE 60310708 T DE60310708 T DE 60310708T DE 60310708 T DE60310708 T DE 60310708T DE 60310708 D1 DE60310708 D1 DE 60310708D1
Authority
DE
Germany
Prior art keywords
plasmid
methods
host cells
vivo
maintaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60310708T
Other languages
English (en)
Other versions
DE60310708T2 (de
Inventor
Julian Hanak
Rocky Cranenburgh
Scott Gorman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cobra Biologics Ltd
Original Assignee
Cobra Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cobra Biologics Ltd filed Critical Cobra Biologics Ltd
Application granted granted Critical
Publication of DE60310708D1 publication Critical patent/DE60310708D1/de
Publication of DE60310708T2 publication Critical patent/DE60310708T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60310708T 2002-05-18 2003-05-19 In vivo stabilsierung von plasmiden Expired - Lifetime DE60310708T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0211459 2002-05-18
GBGB0211459.3A GB0211459D0 (en) 2002-05-18 2002-05-18 Plasmid stabilisation in vivo
PCT/GB2003/002166 WO2003097838A1 (en) 2002-05-18 2003-05-19 Plasmid stabilisation in vivo

Publications (2)

Publication Number Publication Date
DE60310708D1 true DE60310708D1 (de) 2007-02-08
DE60310708T2 DE60310708T2 (de) 2007-10-31

Family

ID=9936960

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310708T Expired - Lifetime DE60310708T2 (de) 2002-05-18 2003-05-19 In vivo stabilsierung von plasmiden

Country Status (11)

Country Link
EP (1) EP1507863B1 (de)
AT (1) ATE349539T1 (de)
AU (1) AU2003232336A1 (de)
DE (1) DE60310708T2 (de)
DK (1) DK1507863T3 (de)
ES (1) ES2279963T3 (de)
GB (1) GB0211459D0 (de)
PT (1) PT1507863E (de)
SI (1) SI1507863T1 (de)
WO (1) WO2003097838A1 (de)
ZA (1) ZA200410202B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005271247A1 (en) * 2004-08-13 2006-02-16 The Trustees Of The University Of Pennsylvania Antibiotic resistance free DNA vaccines
DK2942391T3 (en) 2004-08-13 2018-08-27 Univ Pennsylvania PROCEDURES FOR THE MANUFACTURE OF ANTIBIOTICS-RESISTANCE-FREE VACCINES
MX2011012234A (es) 2009-05-22 2012-03-07 Merial Ltd Plasmido libre de antibiotico.
CA2889069C (en) 2012-10-15 2021-01-26 University Of Maryland, Baltimore Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518395D0 (en) * 1995-09-08 1995-11-08 Therexsys Ltd Plasmid stabilization
US6780405B1 (en) * 2000-04-28 2004-08-24 Avant Immunotherapeutics, Inc. Regulated antigen delivery system (RADS)

Also Published As

Publication number Publication date
SI1507863T1 (sl) 2007-06-30
DE60310708T2 (de) 2007-10-31
ZA200410202B (en) 2006-08-30
EP1507863B1 (de) 2006-12-27
PT1507863E (pt) 2007-03-30
EP1507863A1 (de) 2005-02-23
GB0211459D0 (en) 2002-06-26
WO2003097838A1 (en) 2003-11-27
AU2003232336A1 (en) 2003-12-02
ATE349539T1 (de) 2007-01-15
DK1507863T3 (da) 2007-05-07
ES2279963T3 (es) 2007-09-01

Similar Documents

Publication Publication Date Title
CY1122059T1 (el) Μεθοδος τροποποιησης ευκαρυωτικων κυτταρων
TR201909609T4 (tr) Modifiye edilmiş nükleosidleri içeren rna ve kullanım yöntemleri.
EA200700656A1 (ru) Стабильные жидкие композиции плазмидной днк
EP1476562A4 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
DE69636032D1 (de) Plasmid zur verabreichung von nukleine säuren und verwendungsverfahren
CY1111060T1 (el) Νουκλεϊκα οξεα χρησιμα για την πυροδοτηση της θνησιμοτητας κυτταρων ογκου
ATE332388T1 (de) Methoden zur modifikation eukaryotischer zellen
DE60038011D1 (de) Verbesserung der immunantwort als anwendung in impfstoff und gentherapie
ATE440950T1 (de) Konstrukte und verfahren zur regulation der genexpression
ATE284898T1 (de) Synthetische papillomavirus gene, welche für expression in menschlichen zellen optimiert sind
WO2003076561A3 (en) Recombinase fusion protein with enhanced cellular uptake
DE60310708D1 (de) In vivo stabilsierung von plasmiden
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
ATE365807T1 (de) Hepatitis b virus vektoren für gentherapie
HUP0101355A2 (hu) Fehérjetermelésre és célba juttatására szolgáló genomi szekvenciák
MXPA05008817A (es) Derivados de esteres lipidos de nucleotidos.
WO2003090778A3 (en) Dna vaccine combined with an inducer of tumor cell apoptosis
SI1673391T1 (sl) Modificirana cDNA za visoke ekspresijske nivoje faktorja VIII in njegovih derivatov
DE60002603D1 (de) Phosphor-enthaltende dendrimere als transfektionsagente
RS104404A (en) Control sequences of the human corin gene
ATE315406T1 (de) Semi-allogene antitumor-vakzine mit hla-haplo- identischen antigen-präsentierenden zellen
WO2004001027A8 (en) Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof
WO2002068629A3 (en) Dna constructs for cytoplasmic and mithochondrial expression and methods of making and using same
Toth et al. 691. A Light-Inducible CRISPR/Cas9 System for Control of Endogenous Gene Activation
WO2004032973A3 (en) Use of sns insulator of sea urchin for the gene therapy of erythroid cell diseases

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: HANAK, JULIAN, KEELE ST5 5SP, GB

Inventor name: CRANENBURGH, ROCKY, KEELE ST5 5SP, GB

Inventor name: GORMAN, SCOTT, OXFORD OX4 4GA, GB

8364 No opposition during term of opposition